乳房植入市场－2026-2031年预测

预计到 2025 年，乳房植入市场规模将达到 29.12 亿美元，到 2031 年将达到 45.01 亿美元，复合年增长率为 7.53%。

乳房植入市场正以7.53%的强劲复合年增长率成长，预计到2031年将达到45.01亿美元。这些医疗设备透过外科手术改善乳房的大小和形状，兼具美容和重组的双重功能。乳癌发生率的上升、人们对美学的日益关注、对乳房重建的认识不断提高、植入系统技术的进步以及可支配收入的增加，都是推动市场扩张的因素。

主要市场驱动因素

乳癌盛行率和重组手术

乳房植入常用于乳癌切除术术后的乳房重建手术。乳癌病例的不断增加预计将显着推动市场成长。乳癌是全球最常见的癌症类型。 2020年，全球约有230万例新增乳癌病例，导致约68.5万人死亡。国际癌症研究机构（IARC）估计，到2040年，每年新增乳癌病例将超过300万例（增加40%），每年死亡人数将超过100万人（增加50%）。日益加重的疾病负担导致乳房植入重组手术的持续需求。

美容意识和美容需求

近年来，越来越多的人选择透过整形手术来改善自身外观。社会对美和身材的日益关注推动了隆乳植入市场的发展。根据国际美容整形外科学会（ISAPS）发布的《2023年全球美容整形手术调查报告》，2021年全球整形外科医师实施的手术总数显着增加了19.3%。调查显示，2021年全球共进行了超过1,280万例手术和约1,750万例非手术治疗。隆乳手术是女性最常见的整形手术，显示已被广泛接受和接受。

技术创新

乳房植入材料和设计的创新提高了安全性、耐用性和自然外观。表面处理技术的进步，例如纹理植入，有助于降低植入旋转和包膜挛缩的风险。现代乳房植入通常采用高凝聚性硅胶，即使植入外壳受损，也能保持其形状和完整性。奈米技术也透过创建奈米结构表面来影响乳房植入的研发，这些表面可以促进组织整合并减少包膜挛缩等併发症。先进的3D影像和模拟技术使患者能够在术前预览潜在的手术效果，从而帮助患者做出更明智的决定并提高患者满意度。

经济可及性

各地经济繁荣和可支配收入的成长使得整形手术更加经济实惠，也让隆乳植入在更广泛的人群中流行起来。可支配收入的成长预计将推动市场成长。 2019-20财年，印度可支配所得总额成长6.4%，达204.22兆印度卢比。 2021年，中国人均可支配所得为35,128元人民币（约5,523美元），以名目价值计算年增9.1%。这些经济改善正在扩大整形和重组乳房手术的潜在市场。

市场约束

儘管乳房植入市场呈现成长趋势，但仍面临许多挑战。植入本身的费用、外科医生费用、麻醉费用以及术后护理费用加起来可能是一笔不小的开支。对部分企业而言，经济负担构成了市场扩张的障碍，并可能对市场成长产生负面影响。植入破裂、包膜挛缩、植入相关异生性大细胞淋巴瘤（BIA-ALCL）以及潜在的长期健康影响等问题，引发了人们对乳房植入安全性的担忧。这些担忧导致卫生部门和监管机构加强了审查，可能影响消费者信心和市场需求。製造商必须透过改进设计和提高资讯透明度来持续解决这些安全问题。

区域趋势

预计在预测期内，北美市场将占据显着的市场份额，这主要得益于乳癌病例的增加、可支配收入的成长、健全的医疗保健体係以及对技术创新的早期应用。乳癌是美国第二大常见癌症，约占每年女性新确诊癌症病例的30%。隆乳手术名列美国五大外科手术之列，显示其在北美美容医学领域占有举足轻重的地位。

市场参与企业和近期趋势

主要市场参与企业包括 Polytech Health & Aesthetics GmbH，该公司提供 Polytech Patient Pathway™ 和轻型 B-Lite®植入；Motiva Implants，该公司以其符合人体工学的凝胶填充乳房植入Ergonomix 系列而闻名，该系列植入物旨在适应患者的运动；以及 Groupe 植入 SAS，完整性公司提供在内的乳房植入方案

乳房植入市场持续发展，其驱动力包括技术日益成熟、手术接受度不断提高，以及乳癌术后重组和选择性美容手术的双重需求。安全性不断提升、美学效果更加显着、经济可及性增强，预计这些因素将推动市场持续成长，製造商也将不断创新以应对临床挑战并满足不同患者的偏好。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 依产品分類的乳房植入市场

• 介绍
• 硅胶植入
• 生理食盐水植入

第六章 依形状分類的乳房植入市场

• 介绍
• 圆形的
• 解剖学

第七章 依应用分類的乳房植入市场

• 介绍
• 重组手术
• 整形手术

第八章 各地区乳房植入市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• ALLERGAN（ABBVIE INC.）
• GC Aesthetics
• GROUPE SEBBIN SAS
• J&J MedTech
• Sientra Inc.
• Polytech Health & Aesthetics GmbH
• Motiva Implants
• Guangzhou Wanhe Plastic Materials Co., Ltd.
• LABORATOIRES ARION

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

The breast implants market, with a 7.53% CAGR, is projected to rise from USD 2.912 billion in 2025 to USD 4.501 billion in 2031.

The breast implants market is experiencing robust growth at a 7.53% CAGR, projected to reach USD 4.501 billion in 2031. These medical devices-used to enhance breast size and shape through surgical procedures-serve both cosmetic and reconstructive purposes. Rising breast cancer prevalence, increasing beauty consciousness, awareness about breast reconstruction, technological advancements in implant systems, and rising disposable income are propelling market expansion.

Primary Market Drivers

Breast Cancer Prevalence and Reconstruction

Breast implants are commonly used in breast reconstruction procedures following mastectomy due to breast cancer. Rising breast cancer cases are expected to propel market growth substantially. Breast cancer represents the most prevalent cancer type globally. Approximately 2.3 million new breast cancer instances occurred in 2020, with approximately 685,000 deaths worldwide. The IARC estimates that by 2040, there will be more than 3 million new breast cancer instances annually-a 40% increase-and more than 1 million annual fatalities-a 50% increase. This growing disease burden creates sustained demand for reconstructive procedures utilizing breast implants.

Beauty Consciousness and Cosmetic Demand

Recent years have witnessed growing trends of people seeking cosmetic enhancements to improve physical appearance. Increasing emphasis on beauty and body image in society has driven the breast implants market. According to the 2023 annual Global Survey on Aesthetic/Cosmetic Procedures conducted by the International Society of Aesthetic Plastic Surgery, plastic surgeons worldwide reported a significant 19.3% increase in overall procedures performed in 2021. The survey revealed that more than 12.8 million surgical procedures and approximately 17.5 million non-surgical procedures were conducted globally during that year. Breast augmentation was the most common surgical procedure for women, demonstrating the procedure's mainstream acceptance and popularity.

Technological Innovation

Technological innovations in breast implant materials and design have improved safety, durability, and natural appearance. Advancements in implant surfaces, such as textured implants, have helped reduce the risk of implant rotation and capsular contracture. Modern breast implants often use cohesive silicone gel, which maintains shape and integrity even if the implant shell is compromised. Nanotechnology has influenced breast implant development by creating nanostructured surfaces that enhance tissue integration and reduce complications like capsular contracture. Advanced 3D imaging and simulation technologies allow patients to visualize potential outcomes before undergoing surgery, supporting improved decision-making and patient satisfaction.

Economic Accessibility

Economic prosperity and increasing disposable income in various regions have allowed more individuals to afford cosmetic procedures, making breast implants more accessible to broader demographics. Rising disposable income is expected to bolster market growth. India's gross disposable income witnessed 6.4% growth in fiscal year 2019-20, reaching Rs. 204.22 lakh crore. China's per capita disposable income was 35,128 yuan (approximately $5,523) in 2021, an increase of 9.1% year over year in nominal terms. These economic improvements expand the addressable market for both cosmetic and reconstructive breast procedures.

Market Constraints

Despite positive growth trajectories, the breast implants market faces challenges. The cost of implants, surgeon's fees, anesthesia, and post-operative care may accumulate to significant expenses. Affordability might be a limiting factor for some people, potentially negatively impacting market expansion. Issues such as implant rupture, capsular contracture, implant-associated anaplastic large cell lymphoma (BIA-ALCL), and potential long-term health effects have raised questions about breast implant safety profiles. These concerns have led to increased scrutiny by health authorities and regulatory bodies, potentially affecting consumer confidence and market demand. Manufacturers must continuously address these safety concerns through improved designs and transparent communication.

Regional Dynamics

North America is expected to hold significant market share during the forecast period, supported by rising breast cancer cases, increasing disposable income, strong healthcare systems, and earlier adoption of technological advancements. Breast cancer is the second highest diagnosed cancer in the U.S., contributing to around 30% of all new female cancers each year. Breast augmentation ranks among the top 5 surgical procedures in America, demonstrating the procedure's established position in the region's aesthetic medicine landscape.

Market Players and Recent Developments

Major market players include Polytech Health & Aesthetics GmbH, offering Polytech Patient Pathway(TM) and B-Lite(R) lightweight implants; Motiva Implants, known for Ergonomix range of ergonomic gel-filled breast implants designed to adapt to patient movements; and Groupe Sebbin SAS, providing breast implant solutions including Sensity, Volupty, Purity, and Integrity.

The breast implants market continues evolving, driven by technological sophistication, growing procedural acceptance, and the dual demand from reconstructive needs following breast cancer treatment and elective cosmetic enhancement procedures. The convergence of improved safety profiles, enhanced aesthetic outcomes, and expanding economic accessibility positions the market for sustained growth as manufacturers innovate to address clinical challenges while meeting diverse patient preferences.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Breast Implants Market Segmentation

• By Product
• Silicone Breast Implants
• Saline Breast Implants
• By Shape
• Round
• Anatomical
• By Application
• Reconstructive Surgery
• Cosmetic Surgery
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BREAST IMPLANTS MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Silicone Breast Implants
• 5.3. Saline Breast Implants

6. BREAST IMPLANTS MARKET BY SHAPE

• 6.1. Introduction
• 6.2. Round
• 6.3. Anatomical

7. BREAST IMPLANTS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Reconstructive Surgery
• 7.3. Cosmetic Surgery

8. BREAST IMPLANTS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. ALLERGAN (ABBVIE INC.)
• 10.2. GC Aesthetics
• 10.3. GROUPE SEBBIN SAS
• 10.4. J&J MedTech
• 10.5. Sientra Inc.
• 10.6. Polytech Health & Aesthetics GmbH
• 10.7. Motiva Implants
• 10.8. Guangzhou Wanhe Plastic Materials Co., Ltd.
• 10.9. LABORATOIRES ARION

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations